FundedIQ
Biotechnology

Surrozen: Funding, Investors & Team (Oct 2026)

Surrozen is a biotechnology company that is researching and creating drug candidates that can target the Wnt pathway. They are working on antibodies that can activate the body's natural repair mechanisms in specific tissues, with potential uses in various diseases affecting different parts of the body such as the intestine, liver, eyes, lungs, and nervous system.

surrozen.com LinkedIn South San Francisco, United States 51-100 employees
Biotechnology Emergency Medicine Health Care B2B
Total raised
$193M
Rounds
2
Latest
Undisclosed round
Mar 2025

Surrozen has raised $193M across 2 funding rounds on record, the most recent an undisclosed round of $175M announced in Mar 2025.

That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Surrozen Company Profile and Key Stats

Total funding raised
$193M
across 2 rounds on record
Funding rounds on record
2
Latest funding round
Undisclosed round
$175M in Mar 2025
Employees
51-100
reported band
Headquarters
South San Francisco, United States

Latest funding round on record: Mar 2025.

Surrozen Funding Rounds

Date
Round
Amount
Undisclosed round
$175M
Undisclosed round
$17.5M

Surrozen raised $17.5M in an undisclosed round announced in Apr 2024.

11 months later, an undisclosed round of $175M was announced in Mar 2025.

Surrozen Founders and Leadership Team

Name
Role
Contact
Calvin Kuo
Founder
—

No contact details are on record for this team yet.

Surrozen Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.4M
30,319
$7.7M

Surrozen's latest round of $175M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Surrozen in Biotechnology and South San Francisco

Companies Similar to Surrozen

Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…

Series B $50.0M

Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…

Series A $37.0M
Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

Surrozen Funding FAQs

What does Surrozen do?

Surrozen is a biotechnology company that is researching and creating drug candidates that can target the Wnt pathway. They are working on antibodies that can activate the body's natural repair mechanisms in specific tissues, with potential uses in various diseases affecting different parts of the body such as the intestine, liver, eyes, lungs, and nervous system.

How much funding has Surrozen raised?

Surrozen has raised $193M across 2 rounds on record. The most recent is an undisclosed round of $175M announced in Mar 2025.

When did Surrozen last raise funding?

Surrozen's most recent funding round on record is an undisclosed round of $175M, announced in Mar 2025.

Who founded Surrozen?

FundedIQ lists Calvin Kuo (Founder) at Surrozen.

Where is Surrozen headquartered?

Surrozen is based in South San Francisco, California, United States.

How many employees does Surrozen have?

Surrozen is in the 51-100 employee band.

How does Surrozen's funding compare to other Biotechnology startups?

Surrozen's latest round of $175M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's Surrozen Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Surrozen is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.